FDA lists recall of Apothecary Pharma tirzepatide vials over sterility concerns

The nationwide recall covers 22 vials of a specific tirzepatide product and one vial of a separate NAD+ product. The FDA lists it as ongoing.
Loading coverage...
Independent reporting from across Massachusetts.

The nationwide recall covers 22 vials of a specific tirzepatide product and one vial of a separate NAD+ product. The FDA lists it as ongoing.

Elissa Warner may pursue a limited claim over a warning Amgen could have added after FDA approval. The ruling does not decide whether the drug caused her son's injuries.

The medical examiner will determine the cause and manner of the deaths; investigators have not announced a final fire cause.

The hospital calls the proposal its final offer. The union continues to criticize its wage provisions and is arranging a vote.

The latest patient was likely exposed in Middlesex County. Health officials urged continued mosquito precautions.

The Burlington-led project would test treatments on virtual patient models. Federal funding is tied to research milestones over as many as five years.
Verified schedules will appear here. Check the organizer's official schedule for the latest information.